These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23312048)

  • 1. Health benefits of high-density lipoproteins in preventing cardiovascular diseases.
    Berrougui H; Momo CN; Khalil A
    J Clin Lipidol; 2012; 6(6):524-33. PubMed ID: 23312048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
    Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.
    Diditchenko S; Gille A; Pragst I; Stadler D; Waelchli M; Hamilton R; Leis A; Wright SD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2202-11. PubMed ID: 23868939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
    Cavelier C; Lorenzi I; Rohrer L; von Eckardstein A
    Biochim Biophys Acta; 2006 Jul; 1761(7):655-66. PubMed ID: 16798073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis.
    Zamanian-Daryoush M; Gogonea V; DiDonato AJ; Buffa JA; Choucair I; Levison BS; Hughes RA; Ellington AD; Huang Y; Li XS; DiDonato JA; Hazen SL
    J Biol Chem; 2020 Apr; 295(15):4836-4848. PubMed ID: 32098873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity.
    Berrougui H; Khalil A
    Rejuvenation Res; 2009 Apr; 12(2):117-26. PubMed ID: 19405812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages.
    Uto-Kondo H; Ayaori M; Ogura M; Nakaya K; Ito M; Suzuki A; Takiguchi S; Yakushiji E; Terao Y; Ozasa H; Hisada T; Sasaki M; Ohsuzu F; Ikewaki K
    Circ Res; 2010 Mar; 106(4):779-87. PubMed ID: 20075335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein synthesis and metabolism (Review).
    Zhou L; Li C; Gao L; Wang A
    Mol Med Rep; 2015 Sep; 12(3):4015-4021. PubMed ID: 26082200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen Activates ATP-Binding Cassette Transporter A1-Dependent Efflux Ex Vivo and Improves High-Density Lipoprotein Function in Patients With Hypercholesterolemia: A Double-Blinded, Randomized, and Placebo-Controlled Trial.
    Song G; Lin Q; Zhao H; Liu M; Ye F; Sun Y; Yu Y; Guo S; Jiao P; Wu Y; Ding G; Xiao Q; Qin S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2724-33. PubMed ID: 25978109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and metabolism of high density lipoprotein.
    Sviridov D; Nestel P; Watts G
    Cardiovasc Hematol Agents Med Chem; 2007 Jul; 5(3):215-21. PubMed ID: 17630948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional HDL and atherosclerotic cardiovascular disease.
    Rosenson RS; Brewer HB; Ansell BJ; Barter P; Chapman MJ; Heinecke JW; Kontush A; Tall AR; Webb NR
    Nat Rev Cardiol; 2016 Jan; 13(1):48-60. PubMed ID: 26323267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High density lipoprotein structure-function and role in reverse cholesterol transport.
    Lund-Katz S; Phillips MC
    Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.
    Oku H; Matsuura F; Koseki M; Sandoval JC; Yuasa-Kawase M; Tsubakio-Yamamoto K; Masuda D; Maeda N; Ohama T; Ishigami M; Nishida M; Hirano K; Kihara S; Hori M; Shimomura I; Yamashita S
    FEBS Lett; 2007 Oct; 581(26):5029-33. PubMed ID: 17936760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Postgrad Med J; 2008 Nov; 84(997):590-8. PubMed ID: 19103817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapeutic strategies to enhance HDL function.
    Redondo S; Martínez-González J; Urraca C; Tejerina T
    Lipids Health Dis; 2011 Oct; 10():175. PubMed ID: 21985435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.
    Shao B; Oda MN; Oram JF; Heinecke JW
    Curr Opin Cardiol; 2006 Jul; 21(4):322-8. PubMed ID: 16755201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease.
    Rye KA
    Clin Exp Nephrol; 2014 Apr; 18(2):247-50. PubMed ID: 24052156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.